<DOC>
	<DOCNO>NCT00423241</DOCNO>
	<brief_summary>This study compare clinical performance SEMPERFLO* Pain Management System another commercial pain relief system use 0.5 % bupivacaine follow unilateral , open , inguinal hernia repair procedure . *Trademark</brief_summary>
	<brief_title>SEMPERFLO* Pain Management System Inguinal Hernia Repair</brief_title>
	<detailed_description>Pain evaluate 5 day surgery Subjects follow 30 day surgery .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Inguinal</mesh_term>
	<criteria>Subject candidate primary , nonemergent unilateral , open inguinal hernia repair procedure Subject 18 year old Subject must willing participate study , provide inform consent participate . Subjects undergoing recurrent hernia repair ; Subjects plan undergo another elective surgical procedure prior completion study ; Subjects know allergy bupivacaine ; Subjects immunodeficiency disease ( include know HIV ) ; Subjects finding identify surgeon may preclude conduct study ; Subjects know current alcohol and/or drug abuser ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>